Related references
Note: Only part of the references are listed.Hypoxia and HIF Signaling: One Axis with Divergent Effects
Chiara Corrado et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma
Young Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
CalliSpheres® drug-eluting beads (DEB) transarterial chemoembolization (TACE) is equally efficient and safe in liver cancer patients with different times of previous conventional TACE treatments: a result from CTILC study
X. Zhang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Liver Zonation in Health and Disease: Hypoxia and Hypoxia-Inducible Transcription Factors as Concert Masters
Thomas Kietzmann
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Drug-eluting bead transarterial chemoembolization (TACE) vs conventional TACE in treating hepatocellular carcinoma patients with multiple conventional TACE treatments history A comparison of efficacy and safety
Hui Li et al.
MEDICINE (2019)
The clinical safety and efficacy of conventional transcatheter arterial chemoembolization and drug-eluting beads-transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A meta-analysis
Tao Han et al.
BIOSCIENCE TRENDS (2019)
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
Jean-Luc Raoul et al.
CANCER TREATMENT REVIEWS (2019)
Time-to-progression following conventional compared with drug-eluting-bead transcatheter arterial chemoembolisation in patients with large hepatocellular carcinoma
M-C Ou et al.
CLINICAL RADIOLOGY (2019)
Epidemiology and Management of Hepatocellular Carcinoma
Laura Kulik et al.
GASTROENTEROLOGY (2019)
Efficacy and safety profile of drug-eluting beads transarterial chemoembolization by CalliSpheres® beads in Chinese hepatocellular carcinoma patients
Guan-Hui Zhou et al.
BMC CANCER (2018)
CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study
Baolin Wu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)
Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
Yi-Sheng Liu et al.
BMC GASTROENTEROLOGY (2018)
The diagnosis and treatment of hepatocellular carcinoma
Justin Hartke et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2017)
Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization
Hyungjin Rhee et al.
MODERN PATHOLOGY (2016)
Transarterial chemoembolization: Modalities, indication, and patient selection
Wolfgang Sieghart et al.
JOURNAL OF HEPATOLOGY (2015)
Clinical trial watch: Reports from the AASLD Liver Meeting®, Boston, November 2014
Maria-Carlota Londono et al.
JOURNAL OF HEPATOLOGY (2015)
TRIP: a pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinoma
Amedeo Sciarra et al.
LIVER INTERNATIONAL (2015)
The evolving epidemiology of hepatocellular carcinoma: a global perspective
Michael C. Wallace et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Doxorubicin-loaded Drug-eluting beads Versus Conventional Transarterial Chemoembolization for Nonresectable Hepatocellular Carcinoma
Mohammad Arabi et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2015)
Hepatocellular Carcinoma: Review of Epidemiology, Screening, Imaging Diagnosis, Response Assessment, and Treatment
Toshimasa Clark et al.
CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY (2015)
Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma
Myeong Jun Song et al.
JOURNAL OF HEPATOLOGY (2012)
Transarterial Chemoembolization of Child-A hepatocellular carcinoma: Drug-eluting bead TACE (DEB TACE) vs. TACE with Cisplatin/Lipiodol (cTACE)
Philipp Wiggermann et al.
MEDICAL SCIENCE MONITOR (2011)
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
Johannes Lammer et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization
Andrew L. Lewis et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2006)
Share Paper
